Polymerase Chain Reaction - An Analytical Report, 2009-2015 25th January 2011 The latest PCR market trends with a perceptive attempt to disclose the near-future growth prospects and an in-depth analysis on a geographic basis provide strategic business intelligence.
U.s. Government Grants Awarded For Further Development Of Adult Stem Cell Products 8th November 2010 Regenerative medicine company, Mesoblast Limited (ASX:MSB; USADR:MBLTY), today announced that its United States associate company, Angioblast Systems, has been awarded $1.2 million in grants under the United States Government's Qualifying Therapeutic Discovery Project (QTDP) program.
Australian Couples Give Birth To A Generation Free Of The Psychological Burden 26th October 2010 Scientists call for wider awareness of Preimplantation Genetic Diagnosis for patients at high risk of passing breast cancer genes to their children.
Mesoblast Broadens Cancer Indications For Bone Marrow Transplant Product 14th October 2010 Australian regenerative medicine company Mesoblast Limited (ASX: MSB, USOTC: MBLTY) today announced that it is broadening the oncology applications of its "off-the-shelf" cell product for expansion of haematopoietic stem cells in patients with blood cancers.
Aussie Duo Breakthrough Weight Loss With Dna 13th October 2010 Mr. Matt Patti, Australia’s Exercise Professional of the Year and Mr. Paul Beaver a Doctor of Engineering are both long time devotees to finding the key to unlocking the secrets to achieving sustained health, energy and vitality for women across Australia.
Safety Confirmed Of Breast Augmentation With Autologous Fat Stem Cells 12th October 2010 Since 2003, breast augmentation utilizing stem cells from autologous fat has been developed enabling silicon-free breast reconstruction following cancer surgery.
Submit Biotechnology Articles or Submit Biotechnology Press Releases.